Lise Jamieson

Biographic Data

ID7758331
NAMELise Jamieson
GIVEN NAMESLise
FAMILY NAMEJamieson
SIGNATUREJAMIESON L
AFFILIATIONSUniversity of the Witwatersrand
ORCID0000-0003-2354-4580
VERIFIEDYes
TOTAL WORKS13
TOTAL CITATIONS0
AUTHOR COUNT13
EDITOR COUNT0
FIRST PUBLICATION YEAR2017
LATEST PUBLICATION YEAR2026
H-INDEX0

  • Towards ending tuberculosis in South Africa

    Open AccessLeigh F Johnson, Mmamapudi Kubjane et al.ARTICLEGlobal Health Action2026

  • Leveraging current capacity to address the high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in South Africa

    Open AccessNkgomeleng A Lekodeba, Katherine Snyman et al.ARTICLEPLOS Global Public Health2026

    South Africa has high sexually transmitted infections (STIs) prevalence and currently implements syndromic management, which has limitations including untreated asymptomatic infections and excess antibiotic use. Diagnostic tools like GeneXpert may offer potential improvements. We evaluated potential costs and benefits of GeneXpert for STIs testing. We developed a static analytical model using existing data over a one-year time horizon (January-De…

  • Feasibility and acceptability of unconditional cash transfers intervention among unemployed young adults with first-episode psychosis in South Africa

    Open AccessJoyce Mlay, Lise Jamieson et al.ARTICLEInternational Journal of Mental…2026

    There is a lack of high-quality evidence on cash transfers as an intervention to support young people with first-episode psychosis (FEP) in Africa. To address this gap, we conducted a pilot randomized controlled trial (RCT) with a 3-month follow-up period to assess the feasibility and acceptability of an unconditional cash transfer (UCT) intervention among FEP. We enrolled 60 unemployed young adults (18–29 years) with FEP from three public hospit…

  • Ten-year health impact, economic impact and return on investment of the South African molecular diagnostics programme for HIV, tuberculosis and Sars-CoV-2

    Open AccessBrooke E Nichols, Alexandra de Nooy et al.ARTICLEBMJ Global Health2024

    INTRODUCTION: To ensure there is adequate investment into diagnostics, an understanding of the magnitude of impact and return on investment is necessary. We, therefore, sought to understand the health and economic impacts of the molecular diagnostic programme in South Africa, to deepen the understanding of the broad value of diagnostics and guide future healthcare investments. METHODS: We calculated the 10-year (where data were available) total c…

  • Differential in-hospital mortality and intensive care treatment over time

    Open AccessLise Jamieson, Cari van Schalkwyk et al.ARTICLEPLOS Global Public Health2023

    There are limited published data within sub-Saharan Africa describing hospital pathways of COVID-19 patients hospitalized. These data are crucial for the parameterisation of epidemiological and cost models, and for planning purposes for the region. We evaluated COVID-19 hospital admissions from the South African national hospital surveillance system (DATCOV) during the first three COVID-19 waves between May 2020 and August 2021. We describe proba…

  • The role of modelling and analytics in South African Covid-19 planning and budgeting

    Open AccessGesine Meyer‐Rath, Rachel Hounsell et al.ARTICLEPLOS Global Public Health2023

    Background The South African COVID-19 Modelling Consortium (SACMC) was established in late March 2020 to support planning and budgeting for COVID-19 related healthcare in South Africa. We developed several tools in response to the needs of decision makers in the different stages of the epidemic, allowing the South African government to plan several months ahead. Methods Our tools included epidemic projection models, several cost and budget impact…

  • The National Covid-19 Epi Model (NCEM)

    Open AccessSheetal Silal, Juliet R C Pulliam et al.ARTICLEPLOS Global Public Health2023

    In March 2020 the South African COVID-19 Modelling Consortium was formed to support government planning for COVID-19 cases and related healthcare. Models were developed jointly by local disease modelling groups to estimate cases, resource needs and deaths due to COVID-19. The National COVID-19 Epi Model (NCEM) while initially developed as a deterministic compartmental model of SARS-Cov-2 transmission in the nine provinces of South Africa, was ada…

  • A quantitative assessment of the consistency of projections from five mathematical models of the HIV epidemic in South Africa

    Open AccessHaroon Moolla, Andrew Phillips et al.ARTICLEBMC Public Health2023

    While models produced consistent estimates for several outputs, there are areas of variability that should be investigated. This is important if projections are to be used in subsequent cost-effectiveness studies

  • Assessment of facility-level antiretroviral treatment patient status utilizing a national-level laboratory cohort

    Open AccessJoshua P Murphy, Khumbo Shumba et al.ARTICLEFrontiers in Public Health2022

    Background: Most estimates of HIV retention are derived at the clinic level through antiretroviral (ART) patient management systems, which capture ART clinic visit data, yet these cannot account for silent transfers across HIV treatment sites. Patient laboratory monitoring visits may also be observed in routinely collected laboratory data, which include ART monitoring tests such as CD4 count and HIV viral load, key to our work here. Methods: In t…

  • The cost effectiveness and optimal configuration of HIV self-test distribution in South Africa

    Open AccessLise Jamieson, Leigh F Johnson et al.ARTICLEBMJ Global Health2021

    BACKGROUND: HIV self-testing (HIVST) has been shown to be acceptable, feasible and effective in increasing HIV testing uptake. Novel testing strategies are critical to achieving the UNAIDS target of 95% HIV-positive diagnosis by 2025 in South Africa and globally. METHODS: We modelled the impact of six HIVST kit distribution modalities (community fixed-point, taxi ranks, workplace, partners of primary healthcare (PHC) antiretroviral therapy (ART) …

  • Role of data from cost and other economic analyses in healthcare decision-making for HIV, TB and sexual/reproductive health programmes in South Africa

    Open AccessJoshua P Murphy, Sharon Kgowedi et al.ARTICLEHealth Policy and Planning2021

    An increasing focus on the use of the results of cost analyses and other economic evaluations in health programme decision-making by governments, donors and technical support partners working in low- and middle-income countries is accompanied by recognition that this use is impeded by several factors, including the lack of skills, data and coordination between spheres of the government. We describe our experience generating economic evaluation da…

  • Data quality of drug-resistant tuberculosis and antiretroviral therapy electronic registers in South Africa

    Open AccessLise Jamieson, Denise Evans et al.ARTICLEBMC Public Health2019

    The underreporting of death and the lack of ART or TB status in the electronic DR-TB and ART registers could negatively impact monitoring efforts by downplaying the state of the TB/HIV epidemic. Improved recording of these data sources, and data integration across systems, could improve the accuracy of reporting for the national HIV/ART and TB programs

  • Designing an optimal HIV programme for South Africa

    Open AccessCalvin Chiu, Leigh F Johnson et al.ARTICLEBMC Public Health2017

    Conventional league tables may exaggerate the cost-effectiveness of interventions when programmes are implemented at scale. Accounting for interaction and non-linear scale-up effects provides more realistic estimates in highly saturated real-world settings